Načítá se...
Clinical Symptoms and Microbiological Outcomes in Tuberculosis Treatment Trials
During a recent Food and Drug Administration workshop on clinical trials to evaluate new TB drugs, questions were raised regarding the use of bacteriologic endpoints such as treatment failure and relapse as measures of improvement in health status and long term outcome after treatment. FDA scientist...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3215825/ https://ncbi.nlm.nih.gov/pubmed/21813327 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tube.2011.05.007 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|